At1g13607 Antibody

Shipped with Ice Packs
In Stock

Description

Functional Role of At1g13607

The At1g13607 gene encodes a defensin-like protein, part of a broader family involved in plant innate immunity and stress responses . DEFL proteins are small, cysteine-rich peptides known for antimicrobial activity, often targeting fungal or bacterial pathogens.

Expression Data

A transcriptomic analysis of Arabidopsis infected with Fusarium oxysporum revealed tissue-specific expression patterns for defensin-related genes, including At1g13607 :

TAIR IDDescriptionF1/M1 (Roots)F1/M1 (Shoots)F6/M6 (Roots)F6/M6 (Shoots)
AT1G13607Defensin-like (DEFL) family protein----

Key Observations:

  • No significant differential expression was detected for At1g13607 in roots or shoots under the tested conditions .

  • This suggests context-specific activation, potentially requiring unique stressors or pathogens to induce expression.

Technical Considerations for Antibody Validation

The specificity of plant protein antibodies is critical, as highlighted by studies on non-specific antibodies targeting GPCRs (e.g., AT1 receptor antibodies) :

  • Western Blotting: Valid antibodies should detect a single band at the predicted molecular weight (~10–15 kDa for DEFL proteins).

  • Immunolocalization: Requires confirmation in knockout mutants to rule off-target binding.

Future Research Directions

  • Functional Characterization: Determine the protein’s role in pathogen defense using knockout lines and antibody-based localization.

  • Interaction Networks: Map DEFL protein interactions using co-immunoprecipitation (Co-IP) assays.

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Composition: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
At1g13607 antibody; F13B4 antibody; F21F23 antibody; Defensin-like protein 286 antibody
Target Names
At1g13607
Uniprot No.

Target Background

Database Links

KEGG: ath:AT1G13607

STRING: 3702.AT1G13607.1

UniGene: At.63165

Protein Families
DEFL family
Subcellular Location
Secreted.

Q&A

What is the At1g13607 gene and why are antibodies against it important for plant immunity research?

At1g13607 encodes ATG6, a common and required subunit of phosphatidylinositol 3-kinase (PtdIns3K) complexes in Arabidopsis thaliana. ATG6 plays dual roles in plant cellular functions - it participates in autophagosome nucleation during autophagy and exhibits autophagy-independent functions in plant immunity responses. Antibodies against ATG6 are critical for studying its subcellular localization, protein-protein interactions, and mechanisms underlying its role in plant defense responses. Recent research has revealed that ATG6 interacts with NPR1 (Non-expressor of Pathogenesis-Related genes 1), a key immune regulator, increasing plant resistance to pathogens such as Pseudomonas syringae pv. tomato (Pst) DC3000/avrRps4 .

What are the key applications for At1g13607/ATG6 antibodies in plant immunity studies?

At1g13607/ATG6 antibodies serve multiple crucial functions in plant immunity research:

  • Protein detection and quantification in Western blot analyses

  • Immunoprecipitation to study protein-protein interactions (particularly with NPR1)

  • Immunolocalization to determine subcellular distribution

  • Chromatin immunoprecipitation (ChIP) assays if ATG6 is involved in transcriptional regulation

  • Monitoring ATG6 protein levels during pathogen infection

  • Studying post-translational modifications affecting ATG6 function

These applications have revealed that ATG6 directly interacts with NPR1 and significantly increases nuclear accumulation of NPR1, enhancing plant resistance to pathogen infiltration .

How should researchers validate the specificity of At1g13607/ATG6 antibodies?

Validation of At1g13607/ATG6 antibodies requires multiple approaches:

  • Western blot analysis using:

    • Wild-type plants (positive control)

    • atg6 knockout or knockdown mutants (negative control)

    • Plants overexpressing ATG6 (enhanced signal)

  • Immunoprecipitation followed by mass spectrometry to confirm the identity of the precipitated protein

  • Pre-absorption with recombinant ATG6 protein to confirm specificity

  • Cross-reactivity testing with related ATG proteins to ensure specificity

  • Validation in different plant tissues and under various treatment conditions

Proper validation ensures accurate interpretation of experimental results when studying ATG6-dependent processes in plant immunity .

How can researchers design experiments to investigate ATG6-NPR1 interactions using At1g13607 antibodies?

To investigate ATG6-NPR1 interactions, researchers should implement a multi-faceted experimental approach:

  • Co-immunoprecipitation (Co-IP): Use At1g13607/ATG6 antibodies to pull down protein complexes, followed by NPR1 detection via Western blot (or vice versa)

  • Bimolecular Fluorescence Complementation (BiFC): Verify in vivo interactions by tagging ATG6 and NPR1 with complementary fluorescent protein fragments

  • Yeast Two-Hybrid (Y2H): Confirm direct protein-protein interactions

  • Proximity Ligation Assay (PLA): Detect subcellular sites of interaction using both ATG6 and NPR1 antibodies

  • Subcellular Fractionation: Separate nuclear and cytoplasmic fractions to determine compartment-specific interactions using At1g13607 antibodies

Recent studies have demonstrated that ATG6 and NPR1 co-localize in the nucleus, and ATG6 overexpression significantly increases nuclear accumulation of NPR1, promoting plant immunity against pathogen invasion .

What methodological considerations are important when using At1g13607/ATG6 antibodies to study SINCs-like condensate formation?

When investigating ATG6's role in SINCs (SA-induced NPR1 condensates) formation, researchers should consider:

  • Live Cell Imaging: Use fluorescently tagged proteins alongside antibody-based detection in fixed cells

  • Fixation Protocols: Optimize fixation methods to preserve condensate structures (aldehydes may disrupt some biomolecular condensates)

  • Immunofluorescence Conditions:

    • Test different permeabilization methods

    • Optimize antibody concentrations

    • Use low detergent concentrations to maintain condensate integrity

  • Quantitative Analysis:

    • Number of condensates per cell

    • Size distribution

    • Correlation with stress intensity

  • Temporal Studies: Track condensate formation kinetics after pathogen exposure or SA treatment

Research has shown that ATG6 overexpression significantly increases the formation of SINCs-like condensates, which may be one mechanism by which ATG6 and NPR1 synergistically enhance resistance to pathogen invasion .

How can researchers distinguish between autophagy-dependent and autophagy-independent functions of ATG6 using At1g13607 antibodies?

Distinguishing between the dual functions of ATG6 requires careful experimental design:

  • Use of Autophagy Inhibitors:

    • Apply chemical inhibitors (e.g., Concanamycin A, Wortmannin)

    • Monitor ATG6 and NPR1 protein levels and interactions

  • Genetic Approaches:

    • Use autophagy-deficient mutants (atg5, atg7) while maintaining ATG6 expression

    • Create ATG6 domain mutants that separate autophagy and immunity functions

  • Protein Stability Assays:

    • Cell-free degradation assays with proteasome inhibitors (MG115)

    • Cycloheximide chase experiments in wild-type vs. autophagy-deficient backgrounds

  • Immunoprecipitation Combined with Activity Assays:

    • Pull down ATG6 complexes and assess kinase activity

    • Compare complexes formed under different conditions

Research has shown that autophagy defects do not affect NPR1 protein stability, suggesting that ATG6's role in promoting NPR1 stability may be an autophagy-independent function .

TreatmentEffect on NPR1-GFP DegradationImplication for ATG6 Function
100 μM MG115 (proteasome inhibitor)Significantly inhibited degradationNPR1 degradation is primarily proteasome-dependent
5 μM Concanamycin A (autophagy inhibitor)No significant delay in degradationAutophagy pathway not critical for NPR1 degradation
30 μM Wortmannin (autophagy inhibitor)No significant delay in degradationFurther confirms autophagy-independent regulation
100 μM Cycloheximide in NPR1-GFP vs. NPR1-GFP/atg5 plantsSimilar degradation ratesATG6's role in NPR1 stability is autophagy-independent

What are the best experimental approaches to investigate ATG6's role as a transcriptional coactivator using At1g13607 antibodies?

To study ATG6's potential role as a transcriptional coactivator, researchers should employ:

  • Chromatin Immunoprecipitation (ChIP):

    • Use At1g13607 antibodies to pull down DNA-protein complexes

    • Identify genomic regions where ATG6 binds using sequencing (ChIP-seq)

    • Compare binding patterns with and without pathogen challenge

  • Sequential ChIP (re-ChIP):

    • First immunoprecipitate with NPR1 antibodies, then with ATG6 antibodies

    • Identify regions where both proteins co-localize

  • Transcriptional Assays:

    • Reporter gene constructs with PR1/PR5 promoters

    • Compare activity in wild-type, atg6 mutants, and ATG6 overexpression lines

  • Domain Analysis:

    • Focus on the acidic activation domain (ADD) identified in ATG6 (148-295 AA)

    • Create domain mutants and test transcriptional activity

  • Protein-Protein Interaction Studies:

    • Investigate interactions with known transcription factors like TGAs

    • Compare with other transcriptional coactivators (e.g., EDS1)

Research has demonstrated that ATG6 overexpression significantly enhances the expression of NPR1 downstream genes PR1 and PR5, suggesting that ATG6 might function as a transcriptional coactivator synergistically with NPR1 .

What are the optimal conditions for using At1g13607/ATG6 antibodies in different experimental applications?

ApplicationAntibody DilutionBuffer CompositionIncubation ConditionsSpecial Considerations
Western Blot1:1000-1:5000TBS-T with 3-5% non-fat milkOvernight at 4°CReducing conditions required
Immunoprecipitation2-5 µg per sampleIP buffer with 0.1% NP-404 hours to overnight at 4°CGentle washing to preserve interactions
Immunofluorescence1:100-1:500PBS with 1% BSAOvernight at 4°CMinimal detergent use for condensate preservation
ChIP5-10 µg per sampleChIP dilution bufferOvernight at 4°CCrosslinking optimization crucial
ELISA1:500-1:2000Carbonate buffer (coating)1-2 hours at room temperatureBSA blocking recommended

These conditions should be optimized for each specific antibody and experimental system using appropriate controls .

How can researchers overcome common challenges when working with At1g13607/ATG6 antibodies in plant immunity studies?

Several challenges may arise when using At1g13607 antibodies for plant immunity research:

  • High Background Signal:

    • Increase blocking time and concentration

    • Pre-absorb antibody with plant extract from atg6 mutants

    • Use alternative secondary antibodies

    • Implement more stringent washing protocols

  • Weak Signal Detection:

    • Optimize protein extraction using specialized plant protocols

    • Use signal amplification systems

    • Concentrate samples when necessary

    • Consider epitope exposure techniques (mild denaturation)

  • Cross-Reactivity:

    • Validate with knockout controls

    • Use peptide competition assays

    • Consider generating more specific monoclonal antibodies

    • Use blocking peptides specific to cross-reactive proteins

  • Protein Degradation During Extraction:

    • Use fresh tissue

    • Include comprehensive protease inhibitor cocktails

    • Maintain low temperatures throughout processing

    • Consider extracting under denaturing conditions

  • Variable Results Between Experiments:

    • Standardize plant growth conditions

    • Normalize to consistent reference proteins

    • Use pooled samples when appropriate

    • Document pathogen challenge methods precisely

Implementing these strategies will improve reproducibility and reliability when studying ATG6-dependent processes in plant immunity .

What controls should be included when designing experiments with At1g13607/ATG6 antibodies?

  • Genetic Controls:

    • Wild-type plants (positive control)

    • atg6 knockout/knockdown mutants (negative control)

    • ATG6 overexpression lines (enhanced signal)

    • npr1 mutants (for interaction studies)

    • atg5 or other autophagy-deficient mutants (pathway controls)

  • Technical Controls:

    • No primary antibody control

    • Isotype control (unrelated antibody of same isotype)

    • Pre-immune serum control

    • Secondary antibody only control

    • Peptide competition control

  • Treatment Controls:

    • Mock-infected plants

    • Time-course of infection/treatment

    • SA-treated vs. untreated samples

    • MG115, Concanamycin A, and other inhibitor controls

    • Heat-killed pathogen controls

  • Analysis Controls:

    • Loading controls (housekeeping proteins)

    • Multiple biological and technical replicates

    • Statistical analysis of quantitative data

    • Positive controls from previous publications

Proper implementation of these controls ensures accurate attribution of observed effects to ATG6-specific mechanisms in plant immunity .

How should researchers interpret changes in ATG6 protein levels during pathogen infection?

Interpreting changes in ATG6 protein levels requires careful consideration of several factors:

  • Temporal Dynamics:

    • Early increases may indicate activation of defense pathways

    • Sustained elevation suggests ongoing immune response

    • Late decreases might reflect resolution or exhaustion of defense mechanisms

  • Spatial Distribution:

    • Nuclear accumulation suggests transcriptional regulatory roles

    • Cytoplasmic increases may indicate autophagy activation or SINCs-like condensate formation

    • Membrane association could indicate signaling roles

  • Correlation with Other Markers:

    • Compare with NPR1 nuclear accumulation patterns

    • Correlate with PR gene expression (PR1, PR5)

    • Evaluate relationship with free SA levels

    • Monitor autophagosome formation markers

  • Pathogen-Specific Responses:

    • Different patterns may emerge with different pathogen types

    • Compare virulent vs. avirulent strains (e.g., Pst DC3000 vs. Pst DC3000/avrRps4)

    • Evaluate responses to PAMPs vs. effectors

Research has shown that ATG6 increases NPR1 protein levels and promotes nuclear accumulation of NPR1, which then activates PR gene expression to enhance plant immunity against pathogen invasion .

What statistical approaches are recommended for analyzing experimental data generated using At1g13607/ATG6 antibodies?

Data TypeRecommended Statistical ApproachVisualization MethodSample Size Considerations
Protein abundance (Western blot)ANOVA with post-hoc tests (Tukey's HSD)Box plots, bar graphs with error barsMinimum n=3 biological replicates
Co-localization (microscopy)Pearson's or Mander's correlation coefficientScatter plots, heat maps>30 cells across 3+ biological replicates
Gene expression (qPCR)Student's t-test or ANOVABar graphs with error barsMinimum n=3 biological replicates
Pathogen growthTwo-way ANOVA (time × genotype)Line graphs or box plotsMinimum n=5 biological replicates
Protein-protein interactionsFisher's exact test for enrichmentVenn diagrams, interaction networksMultiple technical replicates
Cell death assaysChi-square testBar graphs, representative images>100 cells across 3+ biological replicates

All data should be checked for normality and homogeneity of variance. Non-parametric alternatives should be used when assumptions are violated. Appropriate statistical software (R, GraphPad Prism) should be employed for analysis .

How can researchers differentiate between direct and indirect effects of ATG6 on NPR1 function?

Differentiating direct from indirect effects requires systematic experimental approaches:

  • In vitro Binding Assays:

    • Use purified recombinant proteins

    • Surface plasmon resonance to measure direct binding

    • Domain mapping to identify interaction interfaces

  • Genetic Approaches:

    • Epistasis analysis with atg6 and npr1 mutants

    • Use of point mutants disrupting specific interactions

    • Time-course analyses after inducible expression

  • Kinetic Studies:

    • Monitor protein interactions immediately after stimulus

    • Determine temporal relationship between ATG6 action and NPR1 effects

    • Use reversible systems to establish causality

  • Pathway Inhibition:

    • Selectively block known mediators

    • Monitor if ATG6-NPR1 interactions persist

    • Use chemical inhibitors of known pathways

  • Proximity-dependent Labeling:

    • BioID or APEX2 fused to ATG6

    • Identify proteins in immediate proximity

    • Compare with NPR1 interactome

Research has demonstrated direct interaction between ATG6 and NPR1 through co-localization and co-immunoprecipitation studies. Furthermore, ATG6 overexpression directly impacts NPR1 protein levels, nuclear accumulation, and the formation of SINCs-like condensates, strongly suggesting direct effects on NPR1 function .

What are the emerging applications of At1g13607/ATG6 antibodies in plant immunity research?

Recent advances have expanded the potential applications of At1g13607/ATG6 antibodies:

  • Biomolecular Condensate Studies:

    • Investigation of ATG6's role in forming SINCs-like condensates

    • Analysis of phase separation properties

    • Identification of other components in these condensates

  • Chromatin Landscape Analysis:

    • ChIP-seq to map ATG6 binding sites genome-wide

    • Integration with chromatin accessibility data

    • Correlation with histone modifications

  • Single-Cell Applications:

    • Antibody-based detection of ATG6 in single-cell proteomics

    • Spatial transcriptomics correlated with ATG6 localization

    • Cell-type specific immunity responses

  • Structural Studies:

    • Antibody-facilitated cryo-EM of ATG6 complexes

    • Structural determination of ATG6-NPR1 interaction interfaces

    • Conformational changes during activation

  • Translational Applications:

    • Development of biosensors based on ATG6-NPR1 interactions

    • Engineering enhanced plant immunity through ATG6 modification

    • Screening for compounds that modulate ATG6-NPR1 interactions

These emerging applications build on the discovery that ATG6 plays a critical role in plant immunity by increasing NPR1 stability, promoting its nuclear accumulation, and enhancing the formation of SINCs-like condensates .

How can researchers apply knowledge from ATG6-NPR1 interactions to improve crop resistance?

Translating ATG6-NPR1 interaction knowledge to crop improvement strategies:

  • Genetic Engineering Approaches:

    • Overexpression of ATG6 to enhance NPR1-mediated immunity

    • Fine-tuning ATG6 expression in specific tissues or developmental stages

    • Engineering of optimized ATG6 variants with enhanced stability or activity

  • Identification of Small Molecule Modulators:

    • Screen for compounds that enhance ATG6-NPR1 interactions

    • Develop agrochemicals that stabilize ATG6 or promote its nuclear localization

    • Identify natural compounds that induce ATG6-dependent immunity

  • Marker-Assisted Breeding:

    • Develop markers for optimal ATG6 alleles in crop species

    • Select for varieties with enhanced ATG6-NPR1 interactions

    • Combine with other immunity-enhancing alleles

  • Diagnostic Applications:

    • Develop antibody-based tools to monitor crop immunity status

    • Create field-applicable diagnostic kits for ATG6 activity

    • Monitor ATG6-NPR1 interactions as predictors of disease resistance

  • Pathway Engineering:

    • Target upstream regulators to enhance ATG6 function

    • Modify downstream components to amplify ATG6-dependent signaling

    • Create synthetic circuits incorporating ATG6-NPR1 modules

These approaches leverage the discovery that ATG6 overexpression increases endogenous SA levels and promotes expression of NPR1 downstream target genes like PR1 and PR5, which are critical for plant immunity .

What methodological advances are needed to better understand the molecular mechanisms of ATG6-mediated immunity?

To advance our understanding of ATG6-mediated immunity, several methodological improvements are needed:

  • Advanced Imaging Techniques:

    • Super-resolution microscopy to visualize ATG6-NPR1 interactions at nanoscale

    • Live-cell imaging with improved temporal resolution

    • Correlative light and electron microscopy for ultrastructural context

  • Proteomics Approaches:

    • Improved methods for membrane protein analysis

    • Higher sensitivity for low-abundance interactors

    • Better quantification of post-translational modifications

    • Pulse-chase proteomics to track protein fate

  • Structural Biology:

    • Cryo-EM structures of ATG6-NPR1 complexes

    • Structural determination of the ATG6 ADD domain (148-295 AA)

    • Hydrogen-deuterium exchange mass spectrometry for dynamic interactions

  • Single-Cell Technologies:

    • Single-cell protein analysis in plant tissues

    • Integration of spatial and temporal data

    • Cell-type specific analysis of ATG6 function

  • Computational Approaches:

    • Improved modeling of protein-protein interactions

    • Systems biology integration of immunity networks

    • Machine learning for predicting functional outcomes of ATG6 variants

Current research has demonstrated that ATG6 significantly enhances NPR1-mediated immunity through multiple mechanisms, including increased nuclear accumulation of NPR1, promotion of SINCs-like condensate formation, and elevated expression of defense genes. Advanced methodologies will help elucidate the precise molecular mechanisms underlying these observations .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.